Martin Birk is a C-level executive with over 16 years of experience driving growth in the biotech and pharma sectors. As a CEO and fractional CFO, he specializes in strategic finance, fundraising, and M&A for startups. He completed the Chief Operating Officer Program at MIT and is described as strategic and goal-oriented.
He is passionate about applying emerging technologies to solve complex challenges in drug development. He recently completed a course exploring the use of AI to assess drug-induced liver injury, a topic highly relevant to his entrepreneurial ventures and recent supply chain certification.
His masters thesis on genetic engineering, focused on creating meganickases from meganucleases, was awarded Best Master Thesis in Life Sciences.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.